We are committed to providing patients and healthcare professionals with safe, high-quality, and reliable pharmaceutical products.
Masanobu Kono
Executive Officer, Head of Quality & Vigilance Division
The mission of the Quality & Vigilance Division is to continue reliably and sustainably providing the universal values of safety and trust that society demands of the pharmaceutical sector. The quality and safety of our pharmaceuticals are fundamental to our business activities, form the foundation of the trust placed in us by patients and healthcare professionals, and embody our commitment to society. Based on these principles, we are working to build and improve reliability across every aspect of our operations: product quality and safety; the soundness of our operational processes; and the human resources and organizational structures that support them.
To respond effectively to rising social expectations and changes in the regulatory environment surrounding the pharmaceutical industry, it is more important than ever to ensure and strengthen safety management and quality assurance. Rather than simply continuing our existing initiatives, we are conducting a comprehensive review of our systems in anticipation of changes in the business environment. Specifically, we are pursuing the following transformations.
- Transitioning to preventative quality assurance focused on preventing problems before they occur
- Improving efficiency and precision of operations using digital technologies such as AI
- Building consistent quality and safety management systems based on global standards
- Strengthening human resources and organizations grounded in expertise and a strong sense of ethics
The Quality & Vigilance Division does more than ensure regulatory compliance. It plays a strategic role in linking business transformation to sustainable growth while appropriately assessing risks. To that end, it is essential that we continually review our operations with our purpose firmly in mind and pursue an optimal approach within the limits of our available resources. We will continue to fulfill our responsibilities for ensuring quality and safety while carefully determining what should be preserved and what should be reviewed.
Providing appropriate safety information that reflects needs in clinical practice, ensuring pharmaceutical quality, and maintaining a stable supply are essential to sustaining the trust placed in us by patients, healthcare professionals, and society. This trust serves as a foundation for our business activities, allowing us to further improve the quality of our research and development, product supply, and decision-making. These improvements, in turn, lead to the Company’s sustainable growth and improved corporate value. By supporting business activities from the standpoints of quality and safety and building trust that remains strong regardless of any changes in the environment, we will contribute both to the Company’s growth and to providing value to society.